Bayer Aktienges ADR (BAYRY)

$7.97 -0.09 (-1.12%)
Market Cap 32.34B
Revenue (ttm) 50.43B
Net Income (ttm) -2.76B
EPS (ttm) N/A
PE Ratio 6.26
Forward PE 6.17
Profit Margin -5.48%
Debt to Equity Ratio 1.26
Volume 283,358
Avg Vol 819,304
Day's Range N/A - N/A
Shares Out 3.93B
Stochastic %K 58%
Beta 0.93
Analysts Sell
Price Target $8.40

Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-c...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 49 214 30 1
Address:
Kaiser-Wilhelm-Allee 1, Leverkusen, Germany
jagadakku
jagadakku Sep. 16 at 3:41 PM
$BAYRY I'm adding every chance I get under 8. Hindsight is 20/20 ... I should've just bought my entire position under 5. This is my long term deep value bracket.
0 · Reply
HereForFunsies
HereForFunsies Sep. 16 at 12:11 PM
$BAYRY frustrating to see this back in the 7s
0 · Reply
Broview
Broview Sep. 13 at 7:41 AM
$BAYRY solid business? Please increase dividend
1 · Reply
scottptts
scottptts Sep. 12 at 10:51 PM
$BAYRY https://www.reuters.com/business/agrichemicals-firm-corteva-explores-splitting-seed-pesticide-units-wsj-reports-2025-09-12/
0 · Reply
HereForFunsies
HereForFunsies Sep. 11 at 5:16 PM
$BAYRY like to see this coming back up towards it's 52 week high. Here's to hoping we can set a new high by end of year.
0 · Reply
11thestate
11thestate Sep. 5 at 4:39 PM
That’s the most useful info you’ve seen on $BAYRY in years. https://11th.com/cases/bayer-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09052025_1 #Bayer #BAYRY
0 · Reply
stocker19
stocker19 Sep. 3 at 7:46 PM
$BAYRY Is Bayer slowly crawling back to life after the most stupid acquisition they've ever made (Monsanto)? Of course greedy , lying, lawyers and clients haven't helped their bottom line.
0 · Reply
prismmarketview
prismmarketview Aug. 27 at 3:04 PM
(OTCMKTS: $BAYRY) #Bayer Gadoquatrane is now under FDA review—designed for MRI imaging at 60% lower gadolinium dose while maintaining diagnostic quality. If approved, it could redefine contrast safety. https://prismmarketview.com/bayers-gadoquatrane-fda-review-underway-and-positioned-as-a-low-dose-mri-game-changer/
0 · Reply
11thestate
11thestate Aug. 22 at 3:07 AM
Losses on $BAYRY aren’t the end of the story. Find out how to recover: https://11th.com/cases/bayer-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08222025_1 #BAYRY
1 · Reply
smartkarma
smartkarma Aug. 20 at 10:18 PM
$BAYRY | Bayer AG: An Insight Into Its Clinical Development "Bayer AG's latest quarterly performance presents a mixed outlook, showing areas of growth and challenges.In terms of financial results, the company's sales remained flat in the first half of 2025" - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/bayer-ag-an-insight-into-its-clinical-development
0 · Reply
Latest News on BAYRY
No data available.
jagadakku
jagadakku Sep. 16 at 3:41 PM
$BAYRY I'm adding every chance I get under 8. Hindsight is 20/20 ... I should've just bought my entire position under 5. This is my long term deep value bracket.
0 · Reply
HereForFunsies
HereForFunsies Sep. 16 at 12:11 PM
$BAYRY frustrating to see this back in the 7s
0 · Reply
Broview
Broview Sep. 13 at 7:41 AM
$BAYRY solid business? Please increase dividend
1 · Reply
scottptts
scottptts Sep. 12 at 10:51 PM
$BAYRY https://www.reuters.com/business/agrichemicals-firm-corteva-explores-splitting-seed-pesticide-units-wsj-reports-2025-09-12/
0 · Reply
HereForFunsies
HereForFunsies Sep. 11 at 5:16 PM
$BAYRY like to see this coming back up towards it's 52 week high. Here's to hoping we can set a new high by end of year.
0 · Reply
11thestate
11thestate Sep. 5 at 4:39 PM
That’s the most useful info you’ve seen on $BAYRY in years. https://11th.com/cases/bayer-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09052025_1 #Bayer #BAYRY
0 · Reply
stocker19
stocker19 Sep. 3 at 7:46 PM
$BAYRY Is Bayer slowly crawling back to life after the most stupid acquisition they've ever made (Monsanto)? Of course greedy , lying, lawyers and clients haven't helped their bottom line.
0 · Reply
prismmarketview
prismmarketview Aug. 27 at 3:04 PM
(OTCMKTS: $BAYRY) #Bayer Gadoquatrane is now under FDA review—designed for MRI imaging at 60% lower gadolinium dose while maintaining diagnostic quality. If approved, it could redefine contrast safety. https://prismmarketview.com/bayers-gadoquatrane-fda-review-underway-and-positioned-as-a-low-dose-mri-game-changer/
0 · Reply
11thestate
11thestate Aug. 22 at 3:07 AM
Losses on $BAYRY aren’t the end of the story. Find out how to recover: https://11th.com/cases/bayer-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08222025_1 #BAYRY
1 · Reply
smartkarma
smartkarma Aug. 20 at 10:18 PM
$BAYRY | Bayer AG: An Insight Into Its Clinical Development "Bayer AG's latest quarterly performance presents a mixed outlook, showing areas of growth and challenges.In terms of financial results, the company's sales remained flat in the first half of 2025" - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/bayer-ag-an-insight-into-its-clinical-development
0 · Reply
scottptts
scottptts Aug. 19 at 7:48 PM
$BAYRY https://finance.yahoo.com/news/bayer-reaches-settlement-over-seattle-183717456.html
0 · Reply
Diefreeandsell
Diefreeandsell Aug. 15 at 3:03 PM
$BAYRY They should make a deal with $IBRX for Anktiva and T-Hank!
1 · Reply
Diefreeandsell
Diefreeandsell Aug. 15 at 3:00 PM
$IBRX $BAYRY Big Pharma CEO's plot to 'silence' thousands of cancer victims ©AFP/Getty Images The company is pursuing appeals to slash payouts and is petitioning the US Supreme Court for broader relief. At the heart of the storm is glyphosate, Roundup's active ingredient, which allows farmers to use the herbicide on genetically modified corn, soybeans and cotton without harming crops. The World Health Organization deemed glyphosate 'probably carcinogenic' in 2015. In 2017, California added it to its Proposition 65 list of cancer-causing chemicals, requiring warning labels on products sold in the state . While many countries have banned or restricted glyphosate, US usage has soared. Scientific studies have linked it to non-Hodgkin lymphoma, a deadly blood cancer. What do you think? Can Antkiva and T-hank help with this non-Hodgkin lymphoma, a deadly blood cancer? No wonder more people get this cancer in USA! https://cen.acs.org/environment/pesticides/Bayer-moves-block-lawsuits-claim/103/web/2025/04
2 · Reply
HereForFunsies
HereForFunsies Aug. 14 at 6:59 PM
$BAYRY Imagine filing a lawsuit for making a bad investment 🤷‍♂️ own your mistakes, don't come after a company for it. Anyone who did their due diligence saw the lawsuits coming 🤦‍♂️ we just didn't expect them to make the impacts that they did.
0 · Reply
11thestate
11thestate Aug. 13 at 11:23 AM
Took a hit on $BAYRY? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/bayer-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08122025_1 #BAYRY
0 · Reply
Dirk1969
Dirk1969 Aug. 12 at 12:26 PM
$BAYRY https://endpoints.news/bayer-licenses-early-stage-kras-cancer-drug-from-kumquat-for-up-to-1-3b/
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 12 at 8:36 AM
Retail Turns Bearish On Bayer After $1.3B Kumquat Cancer Drug Deal $BAYRY https://stocktwits.com/news/equity/markets/retail-turns-bearish-on-bayer-after-1-3-b-kumquat-cancer-drug-deal/chrDy0TRd70
0 · Reply
HereForFunsies
HereForFunsies Aug. 7 at 12:05 PM
$LLY seems a lot like $BAYRY earnings. Good results and raised guidance, giant selloff from little things. Overreactions.
0 · Reply
zenithofinvesting
zenithofinvesting Aug. 7 at 11:07 AM
$BAYRY This is one of the least ethical companies on the planet.
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 6:11 PM
$BAYRY smashes Q2 earnings expectations — but what about sales? 💥 Bayer reported Q2 core earnings of 35 cents per ADR, beating the Zacks Consensus Estimate by 10 cents, thanks to lower interest expenses and tax outlays. Sales dipped 3.6% on a reported basis but still exceeded estimates at $12.18 billion, with a 0.9% increase on a currency and portfolio-adjusted basis. Discover the full breakdown and what’s next for BAYRY 👉 https://www.zacks.com/stock/news/2673479/bayer-beats-on-q2-earnings-and-sales-raises-25-adjusted-sales-view?cid=sm-stocktwits-2-2673479-body-6276&ADID=SYND_STOCKTWITS_TWEET_2_2673479_BODY_6276
0 · Reply
HereForFunsies
HereForFunsies Aug. 6 at 5:03 PM
$BAYRY I get to DCA guys 🥹🥲
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 1:46 PM
$BAYRY just beat Q2 and raised 2025 outlook — bullish setup? Pharma growth is doing the heavy lifting, helping overcome FX pressures and Xarelto headwinds. Full breakdown here 👉 https://www.zacks.com/stock/news/2673479/bayer-beats-on-q2-earnings-and-sales-raises-25-adjusted-sales-view?cid=sm-stocktwits-2-2673479-teaser-6265&ADID=SYND_STOCKTWITS_TWEET_2_2673479_TEASER_6265
0 · Reply